Autologous adoptive immunotherapy with primed antigen-specific T cells or B cells

摘要

The invention relates to methods and compositions for promoting antigen-specific immune responses with an appropriate cytokine bias. More specifically, the present invention relates to methods of using autologous adoptive immunotherapy with antigen-specific, ex vivo-primed T cells or B cells to promote antigen-specific immune responses with a Th1 or Th2 cytokine bias.